索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张兴,申强.促进冠状动脉侧支循环形成的研究进展[J].国际心血管病杂志,2021,02:73-76.
点击复制

促进冠状动脉侧支循环形成的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年02期
页码:
73-76
栏目:
综述
出版日期:
2021-03-20

文章信息/Info

Title:
-
作者:
张兴; 申强
418000 南华大学附属怀化医院心脏中心,湖南省怀化市第一人民医院心内科
Author(s):
-
关键词:
冠状动脉粥样硬化性心脏病;  冠状动脉侧支循环;  增强体外反搏;  伊伐布雷定;  乳内动脉
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.02.003
文献标识码:
-
摘要:
冠状动脉侧支循环是心肌缺血后心肌供血的一种方式,促进冠状动脉侧支循环形成可能成为治疗冠状动脉粥样硬化性心脏病有潜力的治疗方法。该文介绍冠状动脉侧支循环形成的生理机制、评估方式,重点介绍通过药物、康复、手术等方法促进冠状动脉侧支循环形成。
Abstract:
-

参考文献/References

[1] Rajendran S, Shen X, Glawe J, et al. Nitric oxide and hydrogen sulfide regulation of ischemic vascular growth and remodeling[J]. Compr Physiol, 2019, 9(3):1213-1247.
[2] Zhong X, Ge L, Ma J, et al. Microcatheter collateral channel tracking failure in retrograde percutaneous coronary intervention for chronic total occlusion: incidence, predictors, and management[J]. EuroIntervention, 2019, 15(3):e253-e260.
[3] Seiler C, Pohl T, Wustmann K, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study[J]. Circulation, 2001, 104(17):2012-2017.
[4] Zbinden S, Zbinden R, Meier P, et al. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease[J]. J Am Coll Cardiol, 2005, 46(9):1636-1642.
[5] Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial[J]. Lancet, 2004, 363(9411):751-756.
[6] Traupe T, Stoller M, Gloekler S, et al. The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: a randomized controlled trial[J]. Eur J Clin Invest, 2019, 49(1):e13035.
[7] Leone AM, D'Amario D, Cannata F, et al. The effects of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling: a 10-year follow-up of the RIGENERA study[J]. J Clin Med, 2020, 9(4):1214.
[8] Patel SR, Breall JA, Diver DJ, et al. Bradycardia is associated with development of coronary collateral vessels in humans[J]. Coron Artery Dis, 2000, 11(6):467-472.
[9] Godino C, Colombo A, Margonato A. Ivabradine in patients with stable coronary artery disease: a rationale for use in addition to and neyond percutaneous coronary intervention[J]. Clin Drug Investig, 2017, 37(2):105-120.
[10] Gloekler S, Traupe T, Stoller M, et al. The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease[J]. Heart, 2014, 100(2):160-166.
[11] Hohneck AL, Fries P, Stroder J, et al. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease[J]. J Hypertens, 2019, 37(5):1023-1031.
[12] Mengesha HG, Weldearegawi B, Petrucka P, et al. Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials[J]. BMC Cardiovasc Disord, 2017, 17(1):105.
[13] Scheel KW, Ingram LA, Wilson JL. Effects of exercise on the coronary and collateral vasculature of beagles with and without coronary occlusion[J]. Circ Res, 1981, 48(4):523-530.
[14] Zbinden R, Zbinden S, Windecker S, et al. Direct demonstration of coronary collateral growth by physical endurance exercise in a healthy marathon runner[J]. Heart, 2004, 90(11):1350-1351.
[15] Lin S, Chen Y, Li Y, et al. Physical ischaemia induced by isometric exercise facilitated collateral development in the remote ischaemic myocardium of humans[J]. Clin Sci(Lond), 2014, 127(10):581-588.
[16] Mobius-Winkler S, Uhlemann M, Adams V, et al. Coronary collateral growth induced by physical exercise: results of the impact of intensive exercise training on coronary collateral circulation in patients with stable coronary artery disease(EXCITE)trial[J]. Circulation, 2016, 133(15):1438-1448.
[17] Petrovic MT, Djordjevic-Dikic A, Giga V, et al. The coronary arteriogenesis with combined heparin and exercise therapy in chronic refractory angina(CARHEXA)trial: a double-blind, randomized, placebo-controlled stress echocardiographic study[J]. Eur J Prev Cardiol, 2020,Apr 8.[Epub ahead of print].
[18] Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. J Thorac Cardiovasc Surg, 2015, 149(3):e5-e23.
[19] 中国中医药信息学会抗衰老分会, 欧美同学会医师协会血管分会. 物理技术治疗冠心病的实践指南[J]. 生命科学仪器, 2019, 17(4):13-21.
[20] Lin S, Xiao-Ming W, Gui-Fu W. Expert consensus on the clinical application of enhanced external counterpulsation in elderly people(2019)[J]. Aging Med(Milton), 2020, 3(1): 16-24.
[21] Raza A, Steinberg K, Tartaglia J, et al. Enhanced external counterpulsation therapy: past, present, and future[J]. Cardiol Rev, 2017, 25(2):59-67.
[22] Buschmann EE, Utz W, Pagonas N, et al. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation(Art.Net.-2 Trial)[J]. Eur J Clin Invest, 2009, 39(10):866-875.
[23] Gloekler S, Meier P, de Marchi SF, et al. Coronary collateral growth by external counterpulsation: a randomised controlled trial[J]. Heart, 2010, 96(3):202-207.
[24] Picard F, Panagiotidou P, Wolf-Putz A, et al. Usefulness of individual shear rate therapy, new treatment option for patients with symptomatic coronary artery disease[J]. Am J Cardiol, 2018, 121(4):416-422.
[25] Hudson CL, Moritz AR, Wearn JT. The extracardiac anastomoses of the coronary arterises[J]. J Exp Med, 1932, 56(6):919-925.
[26] Battezzati M, Tagliaferro A, Cattaneo AD. Clinical evaluation of bilateral internal mammary artery ligation as treatment coronary heart disease[J]. Am J Cardiol, 1959, 4(2):180-183.
[27] Stoller M, de Marchi SF, Seiler C. Function of natural internal mammary-to-coronary artery bypasses and its effect on myocardial ischemia[J]. Circulation, 2014, 129(25): 2645-2652.
[28] Stoller M, Seiler C. Effect of permanent right internal mammary artery closure on coronary collateral function and myocardial ischemia[J]. Circ Cardiovasc Interv, 2017, 10(6):e005777.
[29] Bockeria OL, Petrosyan AD, Shvartz VA, et al. Long-term results of isolated transmyocardial laser revascularization in combination with the intramyocardial autologous bone marrow stem cells injection[J]. Lasers Med Sci, 2020, 35(5):1111-1117.
[30] Ceccon CL, Duque AS, Gowdak LH, et al. Shock-wave therapy improves myocardial blood flow reserve in patients with refractory angina: evaluation by real-time myocardial perfusion echocardiography[J]. J Am Soc Echocardiogr, 2019, 32(9):1075-1085.
[31] Konigstein M, Giannini F, Banai S. The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives[J]. Eur Heart J, 2018, 39(11):925-933.

备注/Memo

备注/Memo:
通信作者:申强,E-mail:337825375@qq.com
更新日期/Last Update: 2021-03-20